These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4572033)

  • 1. Some discoveries on myasthenia gravis: the background.
    Walker MB
    Br Med J; 1973 Apr; 2(5857):42-3. PubMed ID: 4572033
    [No Abstract]   [Full Text] [Related]  

  • 2. Neostigmine-responsive weakness in the dog, similar to myasthenia gravis.
    Lorenz MD; DeLahunta A; Alstrom DH
    J Am Vet Med Assoc; 1972 Oct; 161(7):795-800. PubMed ID: 5074261
    [No Abstract]   [Full Text] [Related]  

  • 3. The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.
    Johnston JD
    J Hist Neurosci; 2005 Jun; 14(2):121-37. PubMed ID: 16019657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothesis to account for the Mary Walker phenomenon.
    Patten BM
    Ann Intern Med; 1975 Mar; 82(3):411-5. PubMed ID: 123143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Historical view on the development of knowledge about myasthenia gravis. (Introduction to a symposium)].
    Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 1970; 4(3):261-4. PubMed ID: 4917026
    [No Abstract]   [Full Text] [Related]  

  • 6. Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.
    Ohry A
    J Med Biogr; 2009 May; 17(2):73-4. PubMed ID: 19401508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis in the dog.
    Fraser DC; Palmer AC; Senior JE; Parkes JD; Yealland MF
    J Neurol Neurosurg Psychiatry; 1970 Aug; 33(4):431-7. PubMed ID: 4248323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of myasthenia--I.
    Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract]   [Full Text] [Related]  

  • 9. Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
    Keeney AH; Keeney VT
    Doc Ophthalmol; 1997; 93(1-2):125-34. PubMed ID: 9476610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking Down Myasthenic Crisis.
    Wijdicks EFM
    Neurocrit Care; 2020 Jun; 32(3):875-879. PubMed ID: 31981022
    [No Abstract]   [Full Text] [Related]  

  • 11. Mary Broadfoot Walker (1888-1974).
    Johnston JD
    J Neurol; 2007 Sep; 254(9):1306-7. PubMed ID: 18000738
    [No Abstract]   [Full Text] [Related]  

  • 12. "Crisis" in myasthenia gravis: an historical perspective.
    Keesey JC
    Muscle Nerve; 2002 Jul; 26(1):1-3. PubMed ID: 12115943
    [No Abstract]   [Full Text] [Related]  

  • 13. Urecholine in myasthenia gravis.
    SCHWARZ H
    Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F
    Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis in a Fox Terrier litter.
    Jenkins WL; van Dyk E; McDonald CB
    J S Afr Vet Assoc; 1976 Mar; 47(1):59-62. PubMed ID: 1263198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis--the first 100 years in perspective.
    Harvey AM
    Trans Am Clin Climatol Assoc; 1971; 82():149-69. PubMed ID: 4934016
    [No Abstract]   [Full Text] [Related]  

  • 17. The Mary Walker effect: Mary Broadfoot Walker.
    McCarter SJ; Burkholder DB; Klaas JP; Martinez-Thompson JM; Boes CJ
    J R Coll Physicians Edinb; 2019 Sep; 49(3):255-259. PubMed ID: 31497797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myasthenia gravis.
    Flacke W
    N Engl J Med; 1973 Jan; 288(1):27-31. PubMed ID: 4347296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.
    Molenaar PC; Biewenga JE; Van Kempen GT; De Priester JA
    Neuropharmacology; 1993 Apr; 32(4):373-6. PubMed ID: 8497338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.